WHO Issues Dual Health Alerts: Obesity Drug Warning for Young Children, Low Plague Risk in Russia

The World Health Organization issued two significant global health advisories this week – cautioning against the use of obesity medications in children under 10, while also reassuring the public that the risk of a plague epidemic in Russia remains low following the death of a laboratory technician in Siberia.

The twin announcements, both emerging in early October 2026, underscore the WHO's continued role in setting international health standards and monitoring emerging disease threats across the globe.

Obesity Drugs Not Recommended for Young Children

In new global guidelines released Oct. 7, the WHO warned against the use of obesity drugs – including weight-loss injections – for children younger than 10 years old, according to BBC News. The guidelines emphasize that care for young children struggling with obesity should center on healthy eating habits and regular physical exercise rather than pharmaceutical interventions.

The guidance reflects growing concern among global health authorities about the increasing use of weight-loss medications, such as GLP-1 receptor agonists, which have surged in popularity among adults in recent years. The WHO's position draws a clear boundary, signaling that medical treatments of this nature are not appropriate for the youngest patients, according to BBC News.

Plague Death in Siberia Raises, Then Eases, Alarm

Separately, the WHO moved to calm public concern following the death of Darya Shipilova, 28, a laboratory technician who worked at a plague research institute in Siberia, Russia. Shipilova died last week, two days after falling ill, according to The Guardian. Russian media reports suggested she may have become infected following an accident at her workplace, where dangerous pathogens are stored and studied.

The WHO said it has detected no signs of a further outbreak since Shipilova's death, characterizing the risk of a broader epidemic in Russia as low, The Guardian reported. Quarantine measures were implemented in the Irkutsk region following the incident, according to earlier reports cited by The Guardian.

Broader Implications for Global Health Monitoring

The two developments highlight the WHO's dual mandate: setting preventive health standards while simultaneously tracking and responding to acute disease threats. For African nations – many of which rely on WHO guidance to shape domestic health policy – both advisories carry relevance. Childhood obesity rates are rising across parts of the continent, while biosafety and laboratory safety standards remain a concern in several countries.

The WHO has not indicated any elevated risk to regions outside of Russia in connection with the Siberia plague case, and no additional infections have been reported, according to The Guardian.

As global health authorities continue to monitor both situations, the WHO's advisories serve as a reminder of the broad spectrum of challenges facing public health systems worldwide – from chronic disease management in children to the ever-present risk of infectious disease outbreaks linked to laboratory environments.

*Sources: BBC News - Health (Oct. 7, 2026); The Guardian - Health (Oct. 6, 2026)*